Therapeutic strategies targeting DRAM1 might be more broadly applicable against other intracellular pathogens, considering our recent results that DRAM1 also protects against infections with Salmonella enterica serovar Typhimurium and Aspergillus fumigatus [47,48]. Here, DRAM1 is linked to infection.